France Medical Device Industry Outlook 2022 - 2026

Key Market Indicators

France is set to reach 1,450 units of medical technology density by 2026. This is an increase of 1.8% year on year on average since 2003. Meanwhile, French medical product expenditure is projected to reach €22,590 million by 2026. This is a 1.1% average year-on-year growth since 1980. Germany currently holds the top spot in this ranking, with expenditure of €21,480 million in 2021. France, the UK and Italy follow in second, third and fourth place.

France Medical Device Market Data and Forecasts

Improve your Knowledge with the latest Indicators and Trends

• Eyewear Evolution: Contact Lenses and Spectacles Redefining Vision Correction Trends

  The eyewear industry has experienced remarkable transformation over the years. Notably, contact lenses and spectacles dominate the vision correction segment. With technological advancements and increasing consumer demand for more convenient, stylish, and effective eyewear, both manufacturers and consumers are exploring new frontiers in vision correction options.

  Discover more insights

• Optics Industry: Exploring the Diverse Dynamics of the Global Spectacles Market

  The growth trajectory of the global spectacles market is heavily influenced by the rising prevalence of ocular disorders, an aging population, and an unprecedented increase in screen time. Other key factors propelling this sector are the growing awareness about eye health and the focus on style and aesthetics as spectacles...

  Discover more insights

• Medical Equipment: Emerging Dynamics of Special Purpose Needles Market

  The demand for special purpose needles emanates from specific medical procedures requiring precision, such as biopsy, aspiration, or injection into delicate tissues. This demand can be attributed to a growing prevalence of chronic illnesses, and an increasing number of diagnostic and therapeutic procedures stemming from it. Amid surging healthcare expenditures...

  Discover more insights

• Deciphering Diabetes: Evaluating Emerging Treatments through Pipeline Reviews

  The therapeutic landscape for diabetes is witnessing a significant transformation as an array of innovative treatments steadily progresses through clinical pipeline reviews. Unprecedented pharmacological advancements, characterized by both novel mechanisms of action and improved administration protocols, herald an imminent paradigm shift in managing both type 1 and type 2 diabetes.

  Discover more insights

• Orthopedics Industry: Navigating Challenges and Harnessing Technological Advancement for Optimum Performance

  The global orthopedics industry, like many industries in the healthcare sector, faces its own unique set of obstacles. A critical challenge is the increasing regulatory scrutiny which is causing significant delays in the introduction of legislative procedures and prototype releases. Another major challenge is the recruitment and retention of skilled...

  Discover more insights

• 1
• 2
• 3
• 4